More on GLMD

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (4.5 Score)
- Holders

Upcoming Events

- Earnings (7/30/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Galmed Pharma (NQ:GLMD)
Delayed: 0.58 -0.02 (3.33%)
Prev. Close $0.60  
Open$0.59 
52 Wk High$9.70 
52 Wk Low$2.78 
Day High$0.61 
Day Low$0.57 
P/E N/A  
EPS$0.00 
Volume47,272 

Friends, Peers and Foes (?): GPH, RPTX, ZYME KBLB (more...)

Jun 8, 2026 08:36 AM Form POS EX Galmed Pharmaceuticals
Jun 8, 2026 08:33 AM Form 424B3 Galmed Pharmaceuticals
Jun 8, 2026 08:26 AM Form 6-K Galmed Pharmaceuticals For: Jun 08
Jun 8, 2026 08:11 AM Galmed to acquire Colospan for $4.5 million in medical device deal
Jun 8, 2026 08:11 AM Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market
Jun 2, 2026 07:58 AM Form 6-K Galmed Pharmaceuticals For: Jun 02
Jun 2, 2026 07:31 AM Galmed and Tissue Dynamics identify cardiac fibrosis pathway
Jun 2, 2026 07:30 AM Tissue Dynamics and Galmed Unveil Unknown Metabolic Pathway for Cardiac Fibrosis and Heart Failure which Supports the Development of Aramchol for Cardiac Fibrosis
May 14, 2026 07:52 AM Form 6-K Galmed Pharmaceuticals For: May 14
May 14, 2026 07:31 AM Galmed reports 500% bioavailability boost for oral aramchol formulation
View All Articles

Entities mentioned with GLMD

View All Entities